Literature DB >> 3737913

Infantile-onset multisystem inflammatory disease: radiologic findings.

R A Kaufman, D J Lovell.   

Abstract

Infantile-onset multisystem inflammatory disease (IOMID) is a newly recognized disease that is similar to systemic-onset juvenile rheumatoid arthritis (JRA). The clinical symptoms of IOMID include rash, fever, lymphadenopathy, chronic meningitis, uveitis, and a distinct arthropathic condition. Skeletal involvement is surprisingly constant. The long bones become short, bowed, and widened. The metaphyses flare and simulate rickets. Grotesque epiphyses appear fragmented early in the course of the disease but are gradually incorporated into the widened shafts. We observed these and other radiologic findings in the four cases described in the present study. The findings are distinctive and allow for a specific diagnosis.

Entities:  

Mesh:

Year:  1986        PMID: 3737913     DOI: 10.1148/radiology.160.3.3737913

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Miroslawa Nowak; Mustapha Mallah; Jae Jin Chae; Wendy T Watford; Sigrun R Hofmann; Leonard Stein; Ricardo Russo; Donald Goldsmith; Peter Dent; Helene F Rosenberg; Frances Austin; Elaine F Remmers; James E Balow; Sergio Rosenzweig; Hirsh Komarow; Nitza G Shoham; Geryl Wood; Janet Jones; Nadira Mangra; Hector Carrero; Barbara S Adams; Terry L Moore; Kenneth Schikler; Hal Hoffman; Daniel J Lovell; Robert Lipnick; Karyl Barron; John J O'Shea; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2002-12

2.  NOMID--a neonatal syndrome of multisystem inflammation.

Authors:  R P Torbiak; P B Dent; W P Cockshott
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

3.  An infant with chronic articular and cutaneous manifestations: a new syndrome?

Authors:  L A Brueton; I R Sanderson; L Jadresic; J I Harper; M O Savage; B M Ansell
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

4.  Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra.

Authors:  Cristina N Brau-Javier; Jose Gonzales-Chavez; Jorge R Toro
Journal:  Arch Dermatol       Date:  2012-03

Review 5.  Cryopyrin-associated periodic syndromes: diagnosis and management.

Authors:  Takako Miyamae
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

6.  Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA).

Authors:  Suvimol Chirathivat Hill; Madjimbaye Namde; Andrew Dwyer; Andrew Poznanski; Scott Canna; Raphaela Goldbach-Mansky
Journal:  Pediatr Radiol       Date:  2006-11-28

7.  Selective rickets from localized advanced maturation-a case report.

Authors:  Alan E Oestreich
Journal:  Skeletal Radiol       Date:  2018-11-20       Impact factor: 2.199

8.  Effect of anakinra on arthropathy in CINCA/NOMID syndrome.

Authors:  Takako Miyamae; Yutaka Inaba; Gen Nishimura; Masako Kikuchi; Takayuki Kishi; Ryoki Hara; Utako Kaneko; Toshihiko Shinoki; Tomoyuki Imagawa; Shumpei Yokokta
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-16       Impact factor: 3.054

9.  Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease.

Authors:  Valentina Leone; Gianni Presani; Sandra Perticarari; Alberto Tommasini; Sergio Crovella; Alessandro Lenhardt; Paolo Picco; Loredana Lepore
Journal:  Eur J Pediatr       Date:  2003-08-20       Impact factor: 3.183

10.  Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap).

Authors:  Leigh D Church; Sinisa Savic; Michael F McDermott
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.